University of Massachusetts, Worcester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Worcester sits in the top decile of US sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count).
University of Massachusetts, Worcester: 240 sponsored US clinical trials, 30 recruiting.
University of Massachusetts, Worcester sponsors 240 registered US clinical trials on ClinicalTrials.gov, 30 of them currently recruiting, and 177 completed. 23 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Use Disorder, with 4 trials.
Top-decile sponsor footprint
University of Massachusetts, Worcester ranks in the top decile of sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
177 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
240 total, page 3 of 5
Effect of Pre-imaging on Cardiopulmonary Resuscitation (CPR) Pause
NCT04248985
COmmuNity-engaged SimULation Training for Blood Pressure Control
NCT03375918
Effect of CBT Microinterventions on Mechanisms of Behavior Change Among Adults With AUD
NCT03661853
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder
NCT03526354
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
NCT03583008
Unwinding Physician Anxiety
NCT04137081
Shared Decision Making to Improve Goals-of-Care Decisions for Families of Severe Acute Brain Injury Patients
NCT03833375
Physical Therapy Components for Maximum TKR Outcome
NCT03120052
Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions
NCT03224520
Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial
NCT03470194
Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions
NCT03102580
FITLINE: Pediatric Practice-based Obesity Intervention to Support Families
NCT03143660
PRogram In Support of Moms: An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics
NCT02760004
Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin
NCT03589898
Randomized Controlled Trial for Exparel Hip Fracture
NCT03289858
Prehabilitation for Pelvic Cancer: Changes in Setup Variability
NCT03242538
Trevo Aspiration Proximal Flow Control Registry
NCT03199404
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
NCT03065075
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181
Developing Smokers for Smoker (S4S): A Collective Intelligence Tailoring System
NCT02265354
Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers
NCT02973425
Anticoagulation Medical Home
NCT02870296
A System of Safety (SOS)
NCT03104504
Testing a Novel Manual Communication System for Mechanically Ventilated ICU Patients
NCT04105751
Multisystemic Therapy-Emerging Adults Trial
NCT02922335
Testing A Couple-based Program for Alcohol Risk Reduction in the National Guard
NCT03589508
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
NCT02833753
A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department
NCT02665429
The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)
NCT02806713
Weight Management Counseling in Medical Schools
NCT02725905
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
NCT02561481
Asthma Symptom Management Through Mindfulness Training
NCT02275559
Mobile Mindfulness Training for Smoking Cessation
NCT02037360
Adapting Alcohol Behavioral Couple Therapy for Service Members in Post-Deployment
NCT03589521
Simple Changes Weight Loss Intervention
NCT02968615
Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding
NCT02442830
Augmenting Mindfulness Training Through Experience-driven Neurofeedback
NCT02413177
Keeping Weight Off: Brain Changes Associated With Healthy Behaviors
NCT02189187
US Guided Versus BlindI&D for Treatment of Soft Tissue Abscesses in the ED
NCT02264392
System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts
NCT02266277
Healthy Kids & Families: Overcoming Social, Environmental and Family Barriers to Childhood Obesity Prevention
NCT03028233
Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens
NCT01975896
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
NCT02417142
Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation
NCT02218281
Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation
NCT03604523
Trial of Fresh Start Weight Loss Intervention in WIC Participants
NCT02176915
Patient Experience Recommender System for Persuasive Communication Tailoring
NCT02200432
Community Health Workers Using Patient Stories to Support Hypertension Management
NCT02874547
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
NCT02132442
Emergency Department Safety Assessment and Follow-up Evaluation 2
NCT02453243
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 24 |
| Phase 2 | 14 |
| Phase 3 | 11 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the University of Massachusetts, Worcester pipeline
30 recruiting of 240 indexed (13% open); 177 completed (74%).
Phase mix: 23 late (III/IV) vs 38 early (I/II) (early-phase heavy).
Top condition: Alcohol Use Disorder (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Massachusetts, Worcester: open-pipeline peers nationwide
Peers matched on 240 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 240 trials (± recruiting share)
- Incyte Corporation · 239 trials · 15% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Daiichi Sankyo · 236 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this University of Massachusetts, Worcester page
240 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Worcester or any single study.
- 30 of University of Massachusetts, Worcester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Use Disorder is the condition University of Massachusetts, Worcester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Massachusetts, Worcester pipeline card: 240 registered trials from official public datasets.Report a data error.